{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T19:04:20Z","timestamp":1757703860679},"reference-count":118,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ccl.2013.09.012","type":"journal-article","created":{"date-parts":[[2013,11,26]],"date-time":"2013-11-26T05:46:08Z","timestamp":1385444768000},"page":"73-93","source":"Crossref","is-referenced-by-count":6,"title":["Management of ACCF\/AHA Stage C Heart Failure"],"prefix":"10.1016","volume":"32","author":[{"given":"Sasikanth","family":"Adigopula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rey P.","family":"Vivo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene C.","family":"DePasquale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Nsair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario C.","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ccl.2013.09.012_bib1","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/qshc.2005.017640","article-title":"Effect of discharge instructions on readmission of hospitalised patients with heart failure: do all of the Joint Commission on Accreditation of Healthcare Organizations heart failure core measures reflect better care?","volume":"15","author":"VanSuch","year":"2006","journal-title":"Qual Saf Health Care"},{"key":"10.1016\/j.ccl.2013.09.012_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.0000151811.53450.B8","article-title":"Discharge education improves clinical outcomes in patients with chronic heart failure","volume":"111","author":"Koelling","year":"2005","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.ccl.2013.09.012_bib3","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/eurjhf\/hfq056","article-title":"Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis","volume":"12","author":"Davies","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.012_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10741-007-9052-z","article-title":"Exercise training in patients with heart failure: clinical outcomes, safety, and indications","volume":"13","author":"McKelvie","year":"2008","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.ccl.2013.09.012_bib6","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.2009.454","article-title":"Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial","volume":"301","author":"O'Connor","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.012_bib7","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/01.CIR.0000055013.92097.40","article-title":"Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention","volume":"107","author":"Pi\u00f1a","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2003.11.033","article-title":"Exercise training for patients with heart failure: a systematic review of factors that improve mortality and morbidity","volume":"116","author":"Smart","year":"2004","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib9","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/bmj.328.7441.711-b","article-title":"Exercise training meta-analysis of trials in patients with chronic heart failure (ExTraMATCH)","volume":"328","author":"Piepoli","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ccl.2013.09.012_bib10","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3945\/ajcn.110.000174","article-title":"A\u00a0high-sodium diet is associated with acute decompensated heart failure in ambulatory heart failure patients: a prospective follow-up study. Audio, Transactions of the IRE Professional Group on","volume":"93","author":"Arcand","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.ccl.2013.09.012_bib11","doi-asserted-by":"crossref","first-page":"R1294","DOI":"10.1152\/ajpregu.00738.2005","article-title":"Hemodynamic and neuroendocrine responses to changes in sodium intake in compensated heart failure","volume":"290","author":"Damgaard","year":"2006","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib12","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1161\/01.CIR.88.4.1620","article-title":"Abnormalities of sodium handling and of cardiovascular adaptations during high salt diet in patients with mild heart failure","volume":"88","author":"Volpe","year":"1993","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2013.09.012_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004937","article-title":"Effect of longer-term modest salt reduction on blood pressure","author":"He","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccl.2013.09.012_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","author":"Kenchaiah","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib15","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0140-6736(96)07015-8","article-title":"Wasting as independent risk factor for mortality in chronic heart failure","volume":"349","author":"Anker","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib16","doi-asserted-by":"crossref","first-page":"3173","DOI":"10.1161\/CIRCULATIONAHA.106.683482","volume":"115","author":"Arzt","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib17","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1056\/NEJMoa051001","article-title":"Continuous positive airway pressure for central sleep apnea and heart failure","volume":"353","author":"Bradley","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib18","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa022479","article-title":"Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea","volume":"348","author":"Kaneko","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib19","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJM198706043162301","article-title":"Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group","volume":"316","year":"1987","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM199108013250501","article-title":"Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators","volume":"325","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib21","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1001\/jama.1995.03520420066040","article-title":"Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials","volume":"273","author":"Garg","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.012_bib22","doi-asserted-by":"crossref","first-page":"60A","DOI":"10.1016\/S0002-9149(88)80087-0","article-title":"Effects of enalapril on\u00a0mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)","volume":"62","author":"Swedberg","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib23","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. ATLAS Study Group","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib24","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1053\/euhj.1998.1098","article-title":"Long-term survival in severe heart failure in patients treated with enalapril; ten year follow-up of CONSENSUS I","volume":"20","author":"Swedberg","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2013.09.012_bib25","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1056\/NEJMoa010713","article-title":"A\u00a0randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure","volume":"345","author":"Cohn","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib26","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1001\/archinte.164.8.910","article-title":"Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment","volume":"164","author":"Cicardi","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib27","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1388-9842(03)00112-0","article-title":"VALsartan In Acute myocardial iNfarcTion (VALIANT) trial: baseline characteristics in context","volume":"5","author":"Velazquez","year":"2003","journal-title":"Eur J Heart Fail"},{"issue":"9386","key":"10.1016\/j.ccl.2013.09.012_bib28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S0140-6736(03)14284-5","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial","volume":"362","author":"Granger","year":"2003","journal-title":"Lancet"},{"issue":"9386","key":"10.1016\/j.ccl.2013.09.012_bib29","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0140-6736(03)14283-3","article-title":"Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial","volume":"362","author":"McMurray","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib30","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N\u00a0Engl J Med"},{"issue":"9704","key":"10.1016\/j.ccl.2013.09.012_bib31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib32","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1161\/01.CIR.0000146819.43235.A9","article-title":"Mortality and morbidity reduction with Candesartan in patients with chronic heart failure and left ventricular systolic dysfunction: results of the CHARM low-left ventricular ejection fraction trials","volume":"110","author":"Young","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib33","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0140-6736(00)02213-3","article-title":"Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial\u2013the Losartan Heart Failure Survival Study ELITE II","volume":"355","author":"Pitt","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib34","first-page":"9","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib35","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib36","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib37","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1009492","article-title":"Eplerenone in patients with systolic heart failure and mild symptoms","volume":"364","author":"Zannad","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib38","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib39","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1056\/NEJMoa040135","article-title":"Rates of hyperkalemia after publication of the randomized aldactone evaluation study","volume":"351","author":"Juurlink","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib40","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0735-1097(02)02694-3","article-title":"Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines","volume":"41","author":"Bozkurt","year":"2003","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib41","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jacc.2003.12.040","article-title":"Predischarge initiation of carvedilol in patients hospitalized for decompensated heart failure\u2014results of the initiation management predischarge: process for assessment of carvedilol therapy in heart failure (IMPACT-HF) trial","volume":"43","author":"Gattis","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib42","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/euhj.1997.0839","article-title":"Clinical outcome with enalapril in symptomatic chronic heart failure; a dose comparison. The NETWORK Investigators","volume":"19","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2013.09.012_bib43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/B:CARD.0000025756.32499.6f","article-title":"The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN)","volume":"18","author":"Remme","year":"2004","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ccl.2013.09.012_bib44","first-page":"7","article-title":"Effect of metoprolol CR\/XL in chronic heart failure: Metoprolol CR\/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(98)11181-9","article-title":"The cardiac insufficiency bisoprolol study II (CIBIS-II): a randomised trial","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib46","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1056\/NEJM200105313442201","article-title":"Effect of carvedilol on survival in severe chronic heart failure","volume":"344","author":"Packer","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib47","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","article-title":"Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial","volume":"362","author":"Poole-Wilson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib48","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S0140-6736(03)14422-4","article-title":"COMET: a proposed mechanism of action to explain the results and concerns about dose","volume":"362","author":"Hjalmarson","year":"2003","journal-title":"Lancet"},{"issue":"9266","key":"10.1016\/j.ccl.2013.09.012_bib49","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(00)04560-8","article-title":"Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial; the CAPRICORN Investigators","volume":"357","author":"Dargie","year":"2001","journal-title":"Lancet"},{"issue":"21","key":"10.1016\/j.ccl.2013.09.012_bib50","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199605233342101","article-title":"The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group","volume":"334","author":"Packer","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib51","doi-asserted-by":"crossref","first-page":"20","DOI":"10.7326\/0003-4819-65-1-20","article-title":"The effect of beta adrenergic blockade on patterns of urinary sodium excretion. Studies in normal subjects and in patients with heart disease","volume":"65","author":"Epstein","year":"1966","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib52","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/01.CIR.37.1.54","article-title":"Plasma volume expansion resulting from interference with adrenergic function in normal man","volume":"37","author":"Weil","year":"1968","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib53","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1388-9842(03)00150-8","article-title":"Torasemide vs. furosemide in primary care patients with chronic heart failure NYHA II to IV\u2014efficacy and quality of life","volume":"5","author":"M\u00fcller","year":"2003","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.012_bib54","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1345\/aph.1M177","article-title":"A\u00a0comprehensive review of the loop diuretics: should furosemide be first line?","volume":"43","author":"Wargo","year":"2009","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ccl.2013.09.012_bib55","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/0735-1097(96)00161-1","article-title":"Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion","volume":"28","author":"Dormans","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib56","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","article-title":"Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol","volume":"80","author":"Waagstein","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib57","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/j.1875-9114.1994.tb02848.x","article-title":"Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. Torsemide Investigators Group","volume":"14","author":"Patterson","year":"1994","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ccl.2013.09.012_bib58","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/clpt.1986.228","article-title":"Piretanide, a potent diuretic with potassium-sparing properties, for the treatment of congestive heart failure","volume":"40","author":"Sherman","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccl.2013.09.012_bib59","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0002-9343(81)90755-5","article-title":"Effect of diuresis on the performance of the failing left ventricle in man","volume":"70","author":"Wilson","year":"1981","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib60","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(87)91074-9","article-title":"Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure","volume":"2","author":"Richardson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib61","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1136\/hrt.38.2.167","article-title":"Cardiac arrhythmias induced by hypokalaemia and potassium loss during maintenance digoxin therapy","volume":"38","author":"Steiness","year":"1976","journal-title":"Heart"},{"key":"10.1016\/j.ccl.2013.09.012_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1056\/NEJM199808063390607","article-title":"Diuretic therapy","volume":"339","author":"Brater","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib63","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/0009-9236(95)90222-8","article-title":"Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure","volume":"57","author":"Vargo","year":"1995","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.ccl.2013.09.012_bib64","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S0002-9343(01)00903-2","article-title":"Open-label randomized trial of torsemide compared with furosemide therapy for patients with heart failure","volume":"111","author":"Murray","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib65","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00003088-199630030-00004","article-title":"Diuretic combinations in refractory oedema states: pharmacokinetic-pharmacodynamic relationships","volume":"30","author":"Sica","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.ccl.2013.09.012_bib66","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM198606123142404","article-title":"Effect of\u00a0vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study","volume":"314","author":"Cohn","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib67","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/0735-1097(92)90529-V","article-title":"Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial","volume":"19","author":"Fonarow","year":"1992","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib68","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/S1071-9164(99)90001-5","article-title":"Racial differences in response to therapy for heart failure: analysis of the vasodilator-heart failure trials. Vasodilator-Heart Failure Trial Study Group","volume":"5","author":"Carson","year":"1999","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2013.09.012_bib69","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib70","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs033","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.012_bib71","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.CIR.84.5.2181","article-title":"Digoxin. A neurohormonal modulator in heart failure?","volume":"84","author":"Gheorghiade","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib72","doi-asserted-by":"crossref","first-page":"2959","DOI":"10.1161\/01.CIR.0000132482.95686.87","article-title":"Digoxin in the management of cardiovascular disorders","volume":"109","author":"Gheorghiade","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1056\/NEJM199702203360801","article-title":"The effect of digoxin on mortality and morbidity in patients with heart failure. The Digitalis Investigation Group","volume":"336","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib74","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.amjcard.2008.05.068","article-title":"Digoxin and reduction of heart failure hospitalization in chronic systolic and diastolic heart failure","volume":"102","author":"Meyer","year":"2008","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2013.09.012_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002901.pub2","article-title":"Digitalis for treatment of congestive heart failure in patients in sinus rhythm","author":"Hood","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ccl.2013.09.012_bib76","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1001\/jama.1988.03720040031022","article-title":"Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group","volume":"259","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.012_bib77","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM198203253061202","article-title":"Heart failure in outpatients: a randomized trial of digoxin versus placebo","volume":"306","author":"Lee","year":"1982","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib78","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0002-9149(88)90947-2","article-title":"A\u00a0controlled trial of digoxin in congestive heart failure","volume":"61","author":"Guyatt","year":"1988","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib79","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJM198903163201101","article-title":"A\u00a0comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure","volume":"320","author":"DiBianco","year":"1989","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib80","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/cvr\/25.6.453","article-title":"Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation","volume":"25","author":"Matsuda","year":"1991","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ccl.2013.09.012_bib81","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1016\/0002-9149(79)90456-9","article-title":"Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: beneficial effect of an added beta adrenergic blocking agent","volume":"44","author":"David","year":"1979","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib82","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0140-6736(71)92100-3","article-title":"Fallibility of plasma-digoxin in differentiating toxic from non-toxic patients","volume":"2","author":"Fogelman","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib83","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1056\/NEJM197604152941603","article-title":"The serum digitalis concentration\u2014does it diagnose digitalis toxicity?","volume":"294","author":"Ingelfinger","year":"1976","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib84","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ijcard.2007.10.002","article-title":"Diastolic heart failure in the elderly: underlying mechanisms and clinical relevance","volume":"125","author":"McDonald","year":"2008","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib85","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1001\/jama.2013.905","article-title":"Effect of spironolactone on diastolic function and exercise capacity in patients with heart failure with preserved ejection fraction: the Aldo-DHF randomized controlled trial","volume":"309","author":"Edelmann","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ccl.2013.09.012_bib86","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1161\/CIRCULATIONAHA.110.012575","article-title":"Long-term follow-up of participants with heart failure in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"124","author":"Piller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib87","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa0801369","article-title":"Treatment of hypertension in patients 80 years of age or older","volume":"358","author":"Beckett","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jacc.2005.03.051","article-title":"In-hospital mortality in patients with acute decompensated heart failure requiring intravenous vasoactive medications: an analysis from the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"46","author":"Abraham","year":"2005","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib89","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","author":"Yusuf","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ccl.2013.09.012_bib90","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","author":"Massie","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib91","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","author":"Cleland","year":"2006","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ccl.2013.09.012_bib92","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1056\/NEJM199612263352601","article-title":"Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators","volume":"335","author":"Moss","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib93","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1056\/NEJM199912163412503","article-title":"A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators","volume":"341","author":"Buxton","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib94","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib95","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1056\/NEJMoa041489","article-title":"Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction","volume":"351","author":"Hohnloser","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib96","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib97","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJM199711273372202","article-title":"The Antiarrhythmics Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias","volume":"337","author":"Investigators TAVID","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib98","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.CIR.101.11.1297","article-title":"Canadian implantable defibrillator study (CIDS): a randomized trial of the implantable cardioverter defibrillator against amiodarone","volume":"101","author":"Connolly","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib99","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/01.CIR.102.7.748","article-title":"Randomized comparison of antiarrhythmic drug therapy with implantable defibrillators in patients resuscitated from cardiac arrest: the Cardiac Arrest Study Hamburg (CASH)","volume":"102","author":"Kuck","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","article-title":"ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib101","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1056\/NEJM200103223441202","article-title":"Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay","volume":"344","author":"Cazeau","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib102","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa013168","article-title":"Multicenter insync randomized clinical evaluation. Cardiac Resynchronization in Chronic Heart Failure","volume":"346","author":"Abraham","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib103","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa032423","article-title":"Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure","volume":"350","author":"Bristow","year":"2004","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib104","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1056\/NEJMoa050496","article-title":"The effect of cardiac resynchronization on morbidity and mortality in heart failure","volume":"352","author":"Cleland","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib105","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1016\/j.jacc.2008.08.027","article-title":"Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms","volume":"52","author":"Linde","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.ccl.2013.09.012_bib106","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1056\/NEJMoa0906431","article-title":"Cardiac-resynchronization therapy for the prevention of heart-failure events","volume":"361","author":"Moss","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib107","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1056\/NEJMoa1009540","article-title":"Cardiac-resynchronization therapy for mild-to-moderate heart failure","volume":"363","author":"Tang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib108","first-page":"1","article-title":"2011 ACCF\/AHA guideline for coronary artery bypass graft surgery: a report of the American College of Cardiology Foundation\/American heart association task force on practice guidelines","volume":"11","author":"Hillis","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib109","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1161\/01.CIR.91.9.2335","article-title":"Comparison of surgical and medical group survival in patients with left main equivalent coronary artery disease. Long-term CASS experience","volume":"91","author":"Caracciolo","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib110","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1161\/01.CIR.86.1.121","article-title":"Eighteen-year follow-up in the Veterans Affairs Cooperative Study of coronary artery bypass surgery for stable angina. The VA Coronary Artery Bypass Surgery Cooperative Study Group","volume":"86","year":"1992","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib111","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ahj.2007.01.026","article-title":"Revascularization for heart failure","volume":"153","author":"Phillips","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/j.ccl.2013.09.012_bib112","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1056\/NEJMoa1100356","article-title":"Coronary-artery bypass surgery in patients with left ventricular dysfunction","volume":"364","author":"Velazquez","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib113","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1056\/NEJMoa1100358","article-title":"Myocardial viability and survival in ischemic left ventricular dysfunction","volume":"364","author":"Bonow","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib114","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1161\/CIRCULATIONAHA.112.143818","article-title":"Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the randomized ischemic mitral evaluation (RIME) trial","volume":"126","author":"Chan","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.ccl.2013.09.012_bib115","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1009355","article-title":"Percutaneous repair or surgery for mitral regurgitation","volume":"364","author":"Feldman","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib116","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1093\/eurjhf\/hfr029","article-title":"MitraClip(R) therapy in patients with end-stage systolic heart failure","volume":"13","author":"Franzen","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2013.09.012_bib117","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1056\/NEJMoa0900559","article-title":"Coronary bypass surgery with or without surgical ventricular reconstruction","volume":"360","author":"Jones","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2013.09.012_bib118","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2004.07.017","article-title":"Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation","volume":"44","author":"Athanasuleas","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865113000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T11:11:49Z","timestamp":1716203509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865113000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":118,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0733865113000957"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2013.09.012","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}